国邦医药：累计回购约538万股

Group 1 - The company Guobang Pharmaceutical (SH 605507) announced on September 1 that it has repurchased approximately 5.38 million shares through centralized bidding, accounting for 0.96% of the total share capital, with a total expenditure of about 103 million yuan [1][1][1] - The highest and lowest prices for the repurchased shares were 19.88 yuan/share and 18.61 yuan/share, respectively [1][1][1] - As of the report, Guobang Pharmaceutical has a market capitalization of 12.9 billion yuan [1][1][1] Group 2 - For the fiscal year 2024, the revenue composition of Guobang Pharmaceutical is as follows: the pharmaceutical segment accounts for 64.87%, the animal health products segment accounts for 34.24%, and other businesses account for 0.88% [1][1][1]